Matching trials
2,411 results
- Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID): Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID): primary endpoint results, effect…
- Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis: Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dose Finding Study of HP802-247 in Venous Leg Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study of HP802-247 in Venous Leg Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00852995).
- Dose Optimization Trial of CD19 Redirected Autologous T Cells: Complete Statistical AnalysisIndependent statistical analysis of Dose Optimization Trial of CD19 Redirected Autologous T Cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01747486).
- Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI): Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI): primary endpoint results,…
- Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]: Complete Statistical AnalysisIndependent statistical analysis of Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]: primary endpoint results, effect estimate with…
- Dose-Escalation Safety and Pharmacokinetic Study of K305: Complete Statistical AnalysisIndependent statistical analysis of Dose-Escalation Safety and Pharmacokinetic Study of K305: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01304316).
- Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD: Complete Statistical AnalysisIndependent statistical analysis of Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01210560).
- Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation: Complete Statistical AnalysisIndependent statistical analysis of Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections: primary endpoint results, effect estimate with confidence…
- Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients: Complete Statistical AnalysisIndependent statistical analysis of Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DOT-DBSIndependent statistical analysis of Pre-Exposure Prophylaxis (PrEP) Adherence Monitoring Using Dried Blood Spots: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02022657).
- Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Doxazosin for Psychostimulant Dependence: Complete Statistical AnalysisIndependent statistical analysis of Doxazosin for Psychostimulant Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01371851).
- Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin’s Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Doxycycline, Temozolomide and Ipilimumab in Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Doxycycline, Temozolomide and Ipilimumab in Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01590082).
- DREAMIndependent statistical analysis of the DREAM phase 2 dose-ranging trial of intravenous mepolizumab in severe asthma, explaining the negative binomial regression, exacerbation rate ratios, confidence intervals and serious adverse events by dose.
- DREAMM 5Independent statistical analysis of Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM): primary endpoint results, effect estimate with confidence interval,…
- Driving Neuroplasticity With Nerve Stimulation and Modified CIT: Complete Statistical AnalysisIndependent statistical analysis of Driving Neuroplasticity With Nerve Stimulation and Modified CIT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02587234).
- Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DUARTIndependent statistical analysis of Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder: primary endpoint results, effect estimate with confidence interval, sample-size…
- Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus: Complete Statistical AnalysisIndependent statistical analysis of Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury: Complete Statistical AnalysisIndependent statistical analysis of DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- DYNAMOIndependent statistical analysis of A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DysmenorrheaIndependent statistical analysis of Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00517556).
- DYSTANCE 51Independent statistical analysis of Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DYVINIAIndependent statistical analysis of Dysport in Vulvodynia Phase II Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03598777).
- E3 Breast Cancer Taxotere Combination: Complete Statistical AnalysisIndependent statistical analysis of E3 Breast Cancer Taxotere Combination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00494481).
- E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer: Complete Statistical AnalysisIndependent statistical analysis of E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence…
- E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Early Insulin and Development of ARDS: Complete Statistical AnalysisIndependent statistical analysis of Early Insulin and Development of ARDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00605696).
- EASI ACLIndependent statistical analysis of IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ECOSIndependent statistical analysis of Effects of Marijuana on Symptoms of OCD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03274440).